Kazia Therapeutics KZIA
NASDAQ KZIA
$9.27 -0.20 (-2.11%)
At close: Oct 2, 2026 · 4:00 PM EDT

Kazia Therapeutics (KZIA) Non Operating Interest Expenses (2009)

Updated

Kazia Therapeutics' Non Operating Interest Expenses came in at -$576,858 for the year ended Jun 30, 2017.

Analysis

Kazia Therapeutics (KZIA) Non Operating Interest Expenses (2009) Analysis & Trends

Going back to the year ended Dec 31, 2009, Kazia Therapeutics' Non Operating Interest Expenses data covers 7 years.

  • The figure for the year ended Jun 30, 2017 represents the lowest annual Non Operating Interest Expenses since the year ended Dec 31, 2014.
  • Per Business Quant, earlier years put Non Operating Interest Expenses at -$51,936 in the year ended Dec 31, 2015, -$645,172 in the year ended Dec 31, 2014 and -$127,887 in the year ended Dec 31, 2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 281.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -462.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -435.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 247.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Kazia Therapeutics 68.33 Mn 68.33 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2009 -11,000.00
API Access

Kazia Therapeutics Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=KZIA&period=max&api_key=YOUR_API_KEY